e-Drug3D

1504

CABAZITAXEL


INN
CABAZITAXEL

cas 183133-96-2
CLASS

ANTINEOPLASTIC
MICROTUBULE INHIBITOR
HORMONE-REFRACTORY METASTATIC PROSTATE CANCER
TAXANE CLASS
INHIBITION OF MITOTIC AND INTERPHASE CELLULAR FUNCTION

ROUTE (list)

INTRAVENOUS INJECTION

ATC code

L01CD04

PK parameters

VD 4864 LITER
Cl 48.5 LITER / HOUR
PPB 91 PERCENT
t1/2 95 HOUR

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET MICROTUBULE
BINDS TO TUBULIN AND PROMOTES ITS ASSEMBLY INTO MICROTUBULES WHILE SIMULTANEOUSLY INHIBITING DISASSEMBLY

DrugCentral

Tubulin beta UNIPROT P07437 TUBB

Download SDF file Benzenepropanoic acid, beta-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (alphaR,betaS)-

Formula:
C45H57NO14

Calculated chemical properties:

MW 835.92
NB_atoms 60
XLogP 4.57
PSA 165.574
NB_HD 3
NB_HA 15
fsp3 0.58
Lipinski(0=no;1=yes) 0

FDA
NDA 201023 (pdf not found) INN (CABAZITAXEL) JEVTANA KIT (SANOFI AVENTIS US) APPROVAL= AP YEAR= 2010
NDA 207937 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (FRESENIUS KABI USA) APPROVAL= TA YEAR= 2019
NDA 207949 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 207693 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022
NDA 207619 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (BRECKENRIDGE) APPROVAL= AP YEAR= 2022 DISCONTINUED
NDA 207736 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (APOTEX) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 208715 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (SANDOZ) APPROVAL= TA YEAR= 2023
NDA 207718 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (DR REDDYS) APPROVAL= AP YEAR= 2023
NDA 207735 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (BPI LABS LLC) APPROVAL= TA YEAR= 2023
NDA 207381 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (MYLAN LABS LTD) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 207970 (pdf not found) INN (CABAZITAXEL) CABAZITAXEL (ACTAVIS) APPROVAL= AP YEAR= 2024 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL